NEUROPACE, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEUROPACE, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $548.00K, a 275.34% increase year-over-year.
- NEUROPACE, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $10.00K, a 97.40% decline year-over-year.
- NEUROPACE, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $1.00K, a 97.06% decline year-over-year.
- NEUROPACE, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $146.00K, a 175.47% increase year-over-year.
- NEUROPACE, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $593.00K, a 26.79% decline from fiscal 2024.
- NEUROPACE, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $810.00K, a 443.62% increase from fiscal 2023.
- NEUROPACE, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $149.00K, a 3625.00% increase from fiscal 2022.
- NEUROPACE, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $4.00K, a 50.00% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $548.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $10.00K 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $593.00K 10-K · filed 2026-03-03 | |
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $146.00K 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $385.00K 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $810.00K 10-K · filed 2026-03-03 | |
| 2024-09-30 | $34.00K 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $53.00K 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $721.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $149.00K 10-K · filed 2025-03-04 | |
| 2023-09-30 | $8.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $5.00K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $1.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $4.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $2.00K 10-Q · filed 2023-11-06 | |
| 2022-03-31 | $1.00K 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $8.00K 10-K · filed 2023-03-02 | |
| 2021-06-30 | $4.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $4.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $11.00K 10-K · filed 2022-03-10 | |
| 2020-03-31 | $6.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |